Description
The
objective of this report is to define, describe, and forecast the market on the
basis of type, application, medical condition, and region. It provides detailed
information regarding the major factors influencing the growth of the market.
This report also tracks and analyzes competitive developments of the key
players in terms of market developments, product portfolios, and financials
Request Sample Copy of Report- https://www.radiantinsights.com/research/big-data-in-the-healthcare-and-pharmaceutical-industry-2017-2030/request-sample
“Big
Data” originally emerged as a term to describe datasets whose size is beyond
the ability of traditional databases to capture, store, manage and analyze.
However, the scope of the term has significantly expanded over the years. Big
Data not only refers to the data itself but also a set of technologies that
capture, store, manage and analyze large and variable collections of data, to
solve complex problems.
Amid
the proliferation of real-time and historical data from sources such as
connected devices, web, social media, sensors, log files and transactional
applications, Big Data is rapidly gaining traction from a diverse range of
vertical sectors. The healthcare and pharmaceutical industry is no exception to
this trend, where Big Data has found a host of applications ranging from drug
discovery and precision medicine to clinical decision support and population
health management.
SNS
Research estimates that Big Data investments in the healthcare and
pharmaceutical industry will account for nearly $4 Billion in 2017 alone. Led by a plethora of business opportunities
for healthcare providers, insurers, payers, government agencies, pharmaceutical
companies and other stakeholders, these investments are further expected to
grow at a CAGR of more than 15% over the next three years.
The
“Big Data in the Healthcare & Pharmaceutical Industry: 2017 – 2030 –
Opportunities, Challenges, Strategies & Forecasts” report presents an
in-depth assessment of Big Data in the healthcare and pharmaceutical industry
including key market drivers, challenges, investment potential, application
areas, use cases, future roadmap, value chain, case studies, vendor profiles and
strategies. The report also presents market size forecasts for Big Data
hardware, software and professional services investments from 2017 through to
2030. The forecasts are segmented for 8 horizontal submarkets, 5 application
areas, 36 use cases, 6 regions and 35 countries.
The
report comes with an associated Excel datasheet suite covering quantitative
data from all numeric forecasts presented in the report.
Topics Covered
The
report covers the following topics:
- Big Data ecosystem
- Market drivers and barriers
- Enabling technologies, standardization and
regulatory initiatives
- Big Data analytics and implementation models
- Business case, application areas and use
cases in the healthcare and pharmaceutical industry
- 34 case studies of Big Data investments by
healthcare providers, insurers, payers, pharmaceutical companies and other
stakeholders
- Future roadmap and value chain
- Company profiles and strategies of over 240
Big Data vendors
- Strategic recommendations for Big Data
vendors, and healthcare and pharmaceutical industry stakeholders
- Market analysis and forecasts from 2017 till
2030
Country Markets
- Argentina, Australia, Brazil, Canada, China,
Czech Republic, Denmark, Finland, France, Germany, India, Indonesia, Israel, Italy, Japan,
Malaysia, Mexico, Netherlands, Norway, Pakistan, Philippines, Poland, Qatar,
Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden,
Taiwan, Thailand, UAE, UK, USA
Key Findings
The
report has the following key findings:
- In 2017, Big Data vendors will pocket nearly
$4 Billion from hardware, software and professional services revenues in the
healthcare and pharmaceutical industry. These investments are further expected
to grow at a CAGR of more than 15% over the next three years, eventually
accounting for over $5.8 Billion by the end of 2020.
- Through the use of Big Data technologies,
hospitals and other healthcare facilities have been able to achieve cost
reductions of more than 10%, improvements in outcomes by as much as 20% for
certain conditions, growth in revenue by 30%, and increase in patient access to
services by more than 35%.
- Big Data technologies are playing a pivotal
role in accelerating the transition towards accountable and value-based care
models, by enabling the continuous collection, consolidation and analysis of
clinical and operational data from healthcare facilities and other available
data sources.
- Addressing privacy and security concerns is
necessary in order to fully leverage the benefits of Big Data in the healthcare
and pharmaceutical industry. Therefore, it is essential for key stakeholders to
make significant investments in data encryption and cybersecurity, in addition
to adopting defensible de-identification techniques and implementing strict
restrictions on data use
View Full Report at- https://www.radiantinsights.com/research/big-data-in-the-healthcare-and-pharmaceutical-industry-2017-2030
This
report is a complete study of current trends in the market, industry growth
drivers, and restraints. It provides market projections for the coming years.
It includes analysis of recent developments in technology, Porter’s five force
model analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis
About Us
Radiant
Insights is a market research and consulting company offering syndicated
research studies, customized reports, and consulting services. Our market
research studies are designed to facilitate strategic decision making, on the
basis of extensive and in-depth quantitative information, supported by
extensive analysis and industry insights. Using a patented and robust research
methodology, we publish exhaustive research reports covering a host of
industries such as Technology, Chemicals, Materials, and Energy. Radiant
Insights has a strong base of analysts, consultants and domain experts, with
global experience helping us deliver excellence in all research projects we
undertake
Contact Us
Michelle
Thoras
Corporate
Sales Specialist, USA
Radiant
Insights, Inc
201
Spear Street 1100, Suite 3036, San Francisco, CA 94105, United States
Tel:
1-415-349-0054
Toll
Free: 1-888-928-9744
No comments:
Post a Comment